{
  "id": 19886163,
  "title": "Incyte cancels planned Phase 3 ovarian cancer study for CDK2 inhibitor",
  "url": "https://urgent.news/2026/11/13/incyte-cancels-planned-phase-3-ovarian-cancer-study-for-cdk2-inhibitor",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-13T23:29:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/sec-filings/incyte-cancels-planned-phase-3-ovarian-cancer-study-for-cdk2-inhibitor-93CH-5026755"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}